Correlation Between Charter Communications and AIM ImmunoTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Charter Communications and AIM ImmunoTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Charter Communications and AIM ImmunoTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Charter Communications Cl and AIM ImmunoTech, you can compare the effects of market volatilities on Charter Communications and AIM ImmunoTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Charter Communications with a short position of AIM ImmunoTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Charter Communications and AIM ImmunoTech.

Diversification Opportunities for Charter Communications and AIM ImmunoTech

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Charter and AIM is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Charter Communications Cl and AIM ImmunoTech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AIM ImmunoTech and Charter Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Charter Communications Cl are associated (or correlated) with AIM ImmunoTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AIM ImmunoTech has no effect on the direction of Charter Communications i.e., Charter Communications and AIM ImmunoTech go up and down completely randomly.

Pair Corralation between Charter Communications and AIM ImmunoTech

Assuming the 90 days trading horizon Charter Communications Cl is expected to generate 0.35 times more return on investment than AIM ImmunoTech. However, Charter Communications Cl is 2.85 times less risky than AIM ImmunoTech. It trades about 0.15 of its potential returns per unit of risk. AIM ImmunoTech is currently generating about -0.06 per unit of risk. If you would invest  36,777  in Charter Communications Cl on September 2, 2024 and sell it today you would earn a total of  2,618  from holding Charter Communications Cl or generate 7.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Charter Communications Cl  vs.  AIM ImmunoTech

 Performance 
       Timeline  
Charter Communications 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Charter Communications Cl are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Charter Communications unveiled solid returns over the last few months and may actually be approaching a breakup point.
AIM ImmunoTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Charter Communications and AIM ImmunoTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Charter Communications and AIM ImmunoTech

The main advantage of trading using opposite Charter Communications and AIM ImmunoTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Charter Communications position performs unexpectedly, AIM ImmunoTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AIM ImmunoTech will offset losses from the drop in AIM ImmunoTech's long position.
The idea behind Charter Communications Cl and AIM ImmunoTech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance